Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RWJ 26240

Known as: RWJ-26240, RWJ26240 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Propylamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2000
Review
2000
Recent advances in biotransformation of CNS and cardiovascular agents.
Compound biotransformation is a very important research area for drug discovery and development. In this review, publications… Expand
1998
1998
Excretion and metabolism of the antihypertensive agent, RWJ-26240 (McN-5691) in dogs.
The excretion and metabolism of a 2-ethynylbenzenealkanamine analog, antihypertensive RWJ-26240 (McN-5691), in beagle dogs was… Expand
  • figure 1
  • figure 1
  • figure 1
  • table 1
  • figure 2
1998
1998
Biotransformation of an antihypertensive arylalkylamine analogue in the rat.
1. The excretion and metabolism of N-[2-(3,4-dimethoxyphenyl)ethyl]-5-methoxy-N,alpha-dimethyl-2-(phenyl ethynyl… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE